News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Albany Molecular Research, Inc.; Sanofi-Aventis (France) Seeks Injunction Against Dr. Reddy’s Laboratories Ltd.'s
March 24, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Albany Molecular Research Inc (AMRI.O) along with Sanofi Aventis SA's (SASY.PA) U.S. unit sought a preliminary injunction against India's Dr Reddy's Laboratories Ltd (REDY.BO) from distributing a copycat version of allergy drug Allegra-D.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Sanofi (France)
MORE ON THIS TOPIC
Manufacturing
Drugmakers Push FDA To Extend Support to Existing Facilities
November 11, 2025
·
4 min read
·
Nick Paul Taylor
Vaccines
Pesky ‘Macro Factors’—aka RFK Jr.—Come for Vaccine Pharmas’ Wallets
November 7, 2025
·
4 min read
·
Annalee Armstrong
Legal
Delaware Court Denies Pfizer’s Bid To Block Novo-Metsera Deal
November 6, 2025
·
2 min read
·
Tristan Manalac
Regulatory
‘Chaotic’ HHS Overhaul a Wrecking Ball Toward a Better FDA: Former CIO
November 6, 2025
·
5 min read
·
Jef Akst